S1381

What happened: On April 9, 2025, Senator Durbin (D-IL) introduced S. 1381, the Protecting Employees and Retirees in Business Bankruptcies Act of 2025. The bill was read twice and referred to the Senate Committee on the Judiciary. It currently has 5 cosponsors (Hawley, Schatz, Duckworth, Klobuchar, Whitehouse) and remains in early legislative stage with no further action since introduction. The money trail: This bill does not authorize or appropriate any federal spending. Its mechanism is entirely regulatory — it amends Title 11 of the U.S. Code to elevate the priority of employee and retiree claims in Chapter 11 bankruptcy proceedings. The key changes: raising wage priority cap from $10,000 to $20,000 and eliminating the 180-day earnings window; granting priority to severance pay, employee benefit contributions, WARN Act damages, and pension withdrawal liabilities; restricting rejection of collective bargaining agreements; and capping executive compensation in bankruptcy. These provisions impose direct costs on companies entering Chapter 11, not on taxpayers. Structural winners and losers: The clearest losers are capital-intensive, highly unionized companies in sectors with legacy pension obligations — specifically network airlines (UAL, DAL, AAL) and legacy automakers (GM, STLA). These companies would face higher restructuring costs if the bill becomes law. The primary beneficiaries would be unionized employees and retirees, who gain elevated claim priority and expanded protections. For secured lenders and DIP financing providers, the bill increases bankruptcy risk, likely raising credit costs for affected sectors. No pure-play publicly traded companies benefit from this legislative change. Market data context: UAL trades at $88.62 as of April 30, 2026, down 6.7% in the last week from $95.03 on April 16, and down 2.88% over the trailing 7 days. GM trades at $76.62, down 1.8% from $78.05 on April 16, and down 2.42% over the trailing 7 days. Both stocks have shown broad market correlation in recent moves, not specific reaction to S. 1381, which is appropriate given its early legislative stage. The bill has generated no material price discovery in either name. Timeline: As an early-stage referral to the Senate Judiciary Committee, S. 1381 faces a long legislative path. No hearings have been scheduled. No companion bill exists in the House. With 5 cosponsors and a Democratic lead sponsor in a Republican-controlled 119th Congress (2025-2027), passage probability is low in its current form. The bill would need committee markup, floor vote in the Senate, House passage of an identical bill, and presidential signature. This is realistically a multi-year legislative effort, if it advances at all.